Xenetic Biosciences Inc
XBIO
$2.11-0.92%
Delayed · as of Oct 12, 2026, 1:30 PM ET
Mkt cap
$5.71M
EV/Sales
-0.73
P/E ratio
N/A
FY2025 Revenue
$2.98M
EPS (TTM)
$-1.15
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-90.07%
Beta
2.29
Div yield
N/A
Sector
Healthcare
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
Latest reported XBIO revenue for 2025-12-31 was $3.0M. Net income was -$2.7M. Revenue was up 19.0% from 2024-12-31 to 2025-12-31. XBIO currently screens at market cap $5.7M.
Use this XBIO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full XBIO income, balance, and cash tables.
Xenetic Biosciences Inc (XBIO) is a biotechnology company in the Healthcare sector.
Latest cached Xenetic Biosciences Inc (XBIO) revenue for Dec 31, 2025 was $3.0M. Net income was -$2.7M. Statements: https://lician.com/financials/xbio
Xenetic Biosciences Inc (XBIO) market capitalization is $5.7M on the latest cached snapshot.
Xenetic Biosciences Inc (XBIO) cached previous close $2.13; day range $2.11 – $2.27; volume 5,924. Session quote: https://lician.com/quote/xbio
The latest cached XBIO filing is 8-K · Sep 23, 2026. Filings: https://lician.com/sec/xbio